These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6276835)

  • 41. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 43. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Head and neck tumor immunology. II. Humoral immunity.
    Schantz SP; Savage HE; Lee NK
    Cancer Treat Res; 1990; 52():243-63. PubMed ID: 1976369
    [No Abstract]   [Full Text] [Related]  

  • 45. Head and neck cancer antigens recognized by the humoral immune system.
    Monji M; Senju S; Nakatsura T; Yamada K; Sawatsubashi M; Inokuchi A; Nishimura Y
    Biochem Biophys Res Commun; 2002 Jun; 294(3):734-41. PubMed ID: 12056832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contemporary immunologic considerations in head and neck tumors.
    Berlinger NT; Good RA
    Otolaryngol Clin North Am; 1974 Oct; 7(3):859-83. PubMed ID: 4607983
    [No Abstract]   [Full Text] [Related]  

  • 47. Recent advances in immunology with specific reference to otolaryngology.
    Naclerio R
    Otolaryngol Clin North Am; 1985 Nov; 18(4):821-32. PubMed ID: 3909062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proceedings: Cellular immunity in cured cancer patients.
    Twomey PL; Catalona WJ; Chretien PB
    Cancer; 1974 Feb; 33(2):435-40. PubMed ID: 4812762
    [No Abstract]   [Full Text] [Related]  

  • 49. Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer.
    Shillitoe EJ; Greenspan D; Greenspan JS; Hansen LS; Silverman S
    Cancer; 1982 Jun; 49(11):2315-20. PubMed ID: 6280838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of smoking on immunocompetence.
    Chretien PB
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):11-3. PubMed ID: 201813
    [No Abstract]   [Full Text] [Related]  

  • 51. [Delayed skin reaction in head and neck cancer patient].
    Nagata M
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1478-86. PubMed ID: 6609230
    [No Abstract]   [Full Text] [Related]  

  • 52. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
    Ferris RL
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: Cancer immunotherapy.
    Hussey HH
    JAMA; 1974 Jan; 227(4):435. PubMed ID: 4543616
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunologic aspects of head and neck cancer.
    Dichtel WJ
    Ear Nose Throat J; 1981 Oct; 60(10):97-100, 102,-6. PubMed ID: 7308093
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB; Twomey PL; Trahan EE; Catalona WJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract]   [Full Text] [Related]  

  • 56. An immunologic basis for detection of occult primary malignancies of the head and neck.
    Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD
    Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological abnormalities in oral precancers.
    Pillai R; Balaram P; Reddiar KS
    Cancer Lett; 1991 Apr; 57(1):1-6. PubMed ID: 2025876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Future Prospects on neoplasm antigen vaccine therapy for patients with head and neck squamous cell carcinoma].
    Eura M
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Mar; 105(3):201-7. PubMed ID: 12014346
    [No Abstract]   [Full Text] [Related]  

  • 59. Radiation, immunity, can cancer.
    Lancet; 1972 Jul; 2(7770):217-8. PubMed ID: 4114214
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibody to early and late antigens of herpes simplex virus type 1 in patients with oral cancer.
    Shillitoe EJ; Greenspan D; Greenspan JS; Silverman S
    Cancer; 1984 Jul; 54(2):266-73. PubMed ID: 6327004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.